30902661|t|Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord.
30902661|a|Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid leukaemia and gastrointestinal stromal tumors. Being tyrosine kinase inhibitor, imatinib modulates the activities of Abelson gene (c-Abl), Abelson related gene (ARG), platelet-derived growth factor receptor (PDGFR), FMS-like tyrosine kinase 3 (FLT3), lymphocyte-specific protein (Lck), mitogen activated protein kinase (MAPK), amyloid precursor protein intracellular domain (AICD), alpha-synuclein and the stem-cell factor receptor (c-kit). Studies have shown the role of imatinib in modulating the pathophysiological state of a number of disorders affecting brain and spinal cord such as Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis and spinal cord injury. The present review discusses the role of imatinib in the above described disorders and the possible mechanisms involved in these diseases.
30902661	39	47	imatinib	Chemical	MESH:D000068877
30902661	76	81	brain	Disease	MESH:D001927
30902661	99	107	Imatinib	Chemical	MESH:D000068877
30902661	113	128	tyrosine kinase	Gene	7294
30902661	192	224	Philadelphia-chromosome-positive	Disease	MESH:D010677
30902661	225	250	chronic myeloid leukaemia	Disease	MESH:D015451
30902661	255	286	gastrointestinal stromal tumors	Disease	MESH:D046152
30902661	294	309	tyrosine kinase	Gene	7294
30902661	321	329	imatinib	Chemical	MESH:D000068877
30902661	372	377	c-Abl	Gene	25
30902661	380	400	Abelson related gene	Gene	27
30902661	402	405	ARG	Gene	27
30902661	408	447	platelet-derived growth factor receptor	Gene	5159
30902661	449	454	PDGFR	Gene	5159
30902661	457	483	FMS-like tyrosine kinase 3	Gene	2322
30902661	485	489	FLT3	Gene	2322
30902661	521	524	Lck	Gene	3932
30902661	623	638	alpha-synuclein	Gene	6622
30902661	674	679	c-kit	Gene	3815
30902661	713	721	imatinib	Chemical	MESH:D000068877
30902661	800	805	brain	Disease	MESH:D001927
30902661	830	849	Alzheimer's disease	Disease	MESH:D000544
30902661	851	870	Parkinson's disease	Disease	MESH:D010300
30902661	872	878	stroke	Disease	MESH:D020521
30902661	880	898	multiple sclerosis	Disease	MESH:D009103
30902661	903	921	spinal cord injury	Disease	MESH:D013119
30902661	964	972	imatinib	Chemical	MESH:D000068877
30902661	Association	MESH:D000068877	3932
30902661	Association	MESH:D000068877	MESH:D020521
30902661	Association	MESH:D000068877	6622
30902661	Association	MESH:D000068877	25
30902661	Negative_Correlation	MESH:D000068877	MESH:D010677
30902661	Association	MESH:D000068877	3815
30902661	Association	MESH:D000068877	MESH:D000544
30902661	Association	MESH:D000068877	MESH:D009103
30902661	Association	MESH:D000068877	5159
30902661	Association	MESH:D000068877	MESH:D013119
30902661	Negative_Correlation	MESH:D000068877	MESH:D046152
30902661	Negative_Correlation	MESH:D000068877	MESH:D015451
30902661	Association	MESH:D000068877	2322
30902661	Association	MESH:D000068877	27
30902661	Association	MESH:D000068877	MESH:D010300
30902661	Association	MESH:D000068877	MESH:D001927
30902661	Negative_Correlation	MESH:D000068877	7294

